Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Free Cash Flow (2017 - 2021)

Cogent Biosciences has reported Free Cash Flow over the past 5 years, most recently at -$21.2 million for Q4 2021.

  • Quarterly results put Free Cash Flow at -$21.2 million for Q4 2021, down 126.46% from a year ago — trailing twelve months through Dec 2021 was -$60.4 million (down 68.37% YoY), and the annual figure for FY2025 was -$266.0 million, down 27.66%.
  • Free Cash Flow for Q4 2021 was -$21.2 million at Cogent Biosciences, down from -$15.3 million in the prior quarter.
  • Over the last five years, Free Cash Flow for COGT hit a ceiling of -$5.5 million in Q2 2017 and a floor of -$21.2 million in Q4 2021.
  • Median Free Cash Flow over the past 5 years was -$8.7 million (2018), compared with a mean of -$9.8 million.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 31.72% in 2020 and later tumbled 126.46% in 2021.
  • Cogent Biosciences' Free Cash Flow stood at -$5.8 million in 2017, then tumbled by 56.08% to -$9.0 million in 2018, then increased by 6.23% to -$8.5 million in 2019, then dropped by 10.74% to -$9.4 million in 2020, then tumbled by 126.46% to -$21.2 million in 2021.
  • The last three reported values for Free Cash Flow were -$21.2 million (Q4 2021), -$15.3 million (Q3 2021), and -$12.5 million (Q2 2021) per Business Quant data.